ASPA anticorps (AA 39-270)
Aperçu rapide pour ASPA anticorps (AA 39-270) (ABIN1886426)
Antigène
Voir toutes ASPA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 39-270
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 39 and 270 of Aspartoacylase
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.500
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- ASPA (Aspartoacylase (ASPA))
-
Autre désignation
- Aspartoacylase
-
Sujet
-
This gene encodes an enzyme that catalyzes the conversion of N-acetyl_L-aspartic acid (NAA) to aspartate and acetate.NAA is abundant in the brain where hydrolysis by aspartoacylase is thought to help maintain white matter.This protein is an NAA scavenger in other tissues.Mutations in this gene cause Canavan disease.Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq]
-
Poids moléculaire
- 36 kDa
-
ID gène
- 443
Antigène
-